SCAVX
Price
$14.61
Change
-$0.58 (-3.82%)
Updated
Dec 18 closing price
VSIAX
Price
$85.23
Change
-$3.35 (-3.78%)
Updated
Dec 18 closing price
Ad is loading...

SCAVX vs VSIAX

Header iconSCAVX vs VSIAX Comparison
Open Charts SCAVX vs VSIAXBanner chart's image
AB Small Cap Value A
Price$14.61
Change-$0.58 (-3.82%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index Admiral
Price$85.23
Change-$3.35 (-3.78%)
VolumeN/A
CapitalizationN/A
SCAVX vs VSIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
SCAVX vs. VSIAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SCAVX is a Hold and VSIAX is a Hold.

FUNDAMENTALS
Fundamentals
VSIAX has more cash in the bank: 63B vs. SCAVX (626M). VSIAX pays higher dividends than SCAVX: VSIAX (2.01) vs SCAVX (0.23). SCAVX was incepted earlier than VSIAX: SCAVX (10 years) vs VSIAX (13 years). SCAVX is a more actively managed with annual turnover of: 59.00 vs. VSIAX (16.00). SCAVX has a lower initial minimum investment than VSIAX: SCAVX (2500) vs VSIAX (3000). VSIAX annual gain was more profitable for investors over the last year : 16.23 vs. SCAVX (14.35). VSIAX return over 5 years is better than : 52.83 vs. SCAVX (24.08).
SCAVXVSIAXSCAVX / VSIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years13 years-
Gain YTD12.09315.03180%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets626M63B1%
Annual Yield % from dividends0.232.0112%
Returns for 1 year14.3516.2388%
Returns for 3 years-0.3620.67-2%
Returns for 5 years24.0852.8346%
Returns for 10 years52.44105.6550%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALTO1.470.04
+2.80%
Alto Ingredients
ADXN7.80-0.05
-0.64%
Addex Therapeutics Ltd
DCOM33.96-0.84
-2.41%
Dime Community Bancshares
CAVA123.37-3.42
-2.70%
CAVA Group
EWTX30.17-2.52
-7.71%
Edgewise Therapeutics